G protein-coupled receptor kinase 2 (GRK2)–delta-type opioid receptor (DOR) protein-protein interface (GRK2–DOR PPI)

The G protein-coupled receptor kinase 2 (GRK2)–delta-type opioid receptor (DOR) protein-protein interface is a critical regulatory site in the opioid signaling pathway (UniProt P25098, P41143). GRK2 is a serine/threonine kinase that specifically recognizes and phosphorylates the agonist-activated form of the delta opioid receptor, primarily at its C-terminal tail (Kouhen et al., 1999, BMC Pharmacology). This phosphorylation event facilitates the recruitment of beta-arrestins, which physically uncouple the receptor from G proteins and initiate receptor internalization via clathrin-coated pits (Aguila et al., 2007, Journal of Biological Chemistry). By targeting this specific interface, researchers aim to prevent the desensitization of DOR, thereby enhancing and prolonging the analgesic and antidepressant effects of delta-selective agonists (Terman et al., 2004, Journal of Neuroscience). This approach is particularly relevant in the context of chronic pain and mood disorders, where maintaining receptor sensitivity is crucial for therapeutic efficacy. Unlike global kinase inhibitors, targeting the PPI offers a strategy to achieve receptor-specific modulation, potentially reducing off-target effects associated with the broad substrate profile of GRK2.

Other names

GRK2-DOR interfaceADRBK1-OPRD1 interfaceG protein-coupled receptor kinase 2-delta opioid receptor complexGRK2-delta opioid receptor interaction

The mechanism involves the disruption of the physical binding between the GRK2 enzyme and the activated delta opioid receptor. By preventing this association, the kinase is unable to phosphorylate the receptor's C-terminus, which in turn blocks the recruitment of beta-arrestin proteins. This prevents the uncoupling of the receptor from its G protein partners and halts the process of receptor internalization, thereby maintaining active signaling at the cell surface and potentially reducing the development of opioid tolerance.